SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-018092
Filing Date
2019-03-08
Accepted
2019-03-08 16:17:33
Documents
1
Period of Report
2019-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4635
  Complete submission text file 0001209191-19-018092.txt   6185
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY, SUITE 100 PARSIPPANY NJ 07054
Business Address
Kronenfeld Mark A. (Reporting) CIK: 0001578074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 19669304